Use of vitamin B6 to mitigate visual field defects associated with the use of GABAergic drugs in mammals
AssigneeBrookhaven Science Associates, LLC
InventorCharles R. Ashby, Jr.
Life of this patent
Estimating the term…
Abstract
The invention provides a method for treating visual field defects in a mammal in need thereof by administering an effective amount of vitamin B6 to the mammal.
Claims8
A method for treating visual field defects in a mammal in need thereof comprising administering an effective amount of vitamin B6 to the mammal, wherein the amount of vitamin B6 is about 50 mg/day to about 100 mg/day.
A method for treating visual field defects in a mammal in need thereof comprising administering an effective amount of vitamin B6 to the mammal, wherein the amount of vitamin B6 is about 10 mg/day to about 50 mg/day.
A method for treating visual field defects in a mammal that has, is, or will be taking a GABAergic drug without blocking therapeutic effects of the GABAergic drug, the method comprises administering vitamin B6 in an amount of about 50 mg/day to about 100 mg/day to the mammal.
A method for treating visual field defects in a mammal that has, is, or will be taking a GABAergic drug, without blocking therapeutic effects of the GABAergic drug, the method comprises administering vitamin B6 in an amount of about 10 mg/day to about 50 mg/day to the mammal.
Dependencies are inferred from the claim text.